California · Medicaid and GLP-1s

Does California Medicaid cover Wegovy or Zepbound?

Last updated

No: California Medicaid ended its GLP-1 coverage for weight loss after October 2025.

Without Medicaid: the lowest cash prices in California

  • Lowest compounded semaglutide in California on a monthly plan, not FDA-approved

    Sunlight

    $78/mo

  • Compounded semaglutide, not FDA-approved: at a seller we link to

    Eden

    $99/mo · about $22 more per 30 days than Sunlight

  • Compounded tirzepatide, not FDA-approved: at a seller we link to

    Eden

    $129/mo · about $12 more per 30 days than FlatRx

  • F

    Lowest compounded tirzepatide in California on a monthly plan, not FDA-approved

    FlatRx

    $118/mo

  • Next lowest per 30 days, supply stated: compounded tirzepatide in California

    SexyMD

    $129/mo · ≈ $138 per 30 days

  • Lowest compounded liraglutide in California on a monthly plan, not FDA-approved

    NuBloom

    $408.99/4 weeks

No. KFF found 16 programs covering GLP-1s for obesity treatment in October 2025, and California Medicaid is one of four that "have eliminated coverage of GLP-1s for obesity treatment" since (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026). Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Paying cash in California, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $78/mo at Sunlight and compounded tirzepatide from $118/mo at FlatRx. Compounded medicines are not FDA-approved.

Questions

California Medicaid and GLP-1s: common questions

Does California Medicaid cover Wegovy?

For weight loss alone, no: California Medicaid ended its GLP-1 coverage for weight loss after October 2025. Every Medicaid program must cover Wegovy for the treatment of cardiovascular disease, KFF notes, with the state's own criteria. Wegovy not covered: the cash price at your dose

Does California Medicaid cover Zepbound?

For weight loss alone, no: California Medicaid ended its GLP-1 coverage for weight loss after October 2025. Every Medicaid program must cover Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, KFF notes, with the state's own criteria. Zepbound not covered: the cash price at your dose

Does California Medicaid cover Ozempic or Mounjaro?

For type 2 diabetes, yes: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively." Ozempic and Mounjaro are approved for type 2 diabetes. For weight loss alone, no: California Medicaid ended its GLP-1 coverage for weight loss after October 2025.

How much do Wegovy and Zepbound alternatives cost in California without Medicaid?

Paying cash in California, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $78/mo at Sunlight and compounded tirzepatide from $118/mo at FlatRx. Compounded medicines are not FDA-approved. Semaglutide: advertised as $78/mo at Sunlight, checked Nov 11, 2026 on sunlight.com. Tirzepatide: advertised as $118/mo at FlatRx, checked Nov 17, 2026 on flatrx.io. Liraglutide: advertised as $408.99/4 weeks at NuBloom, checked Nov 14, 2026 on mynubloom.com. Every compounded price in California

Which states' Medicaid covers GLP-1s for weight loss?

10 programs, by KFF's January 2026 map and the states' own notices since: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. Every state's Medicaid and GLP-1s

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

What a Medicaid plan covers is decided by the plan and the state, and changes; ask your plan before you rely on it. This page reports the state's and KFF's published words and sellers' own prices, not insurance or medical advice. Compounded medications are not FDA-approved. GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.